Yao W - Search Results

1

Central venous access devices implantation in children with severe hemophilia a: data from the children comprehensive care center of China.

Xu Q, Wang C, Cheng W, Zhen Y, Ding Y, Liu G, Yao W, Chen Z, Li Z, Wu R. Xu Q, et al. Among authors: yao w. Heliyon. 2023 Feb 11;9(3):e13666. doi: 10.1016/j.heliyon.2023.e13666. eCollection 2023 Mar. Heliyon. 2023. PMID: 36873489 Free PMC article.

2

The Efficacy of Recombinant FVIII Low-Dose Prophylaxis in Chinese Pediatric Patients With Severe Hemophilia A: A Retrospective Analysis From the ReCARE Study.

Yao W, Xiao J, Cheng X, Feng G, Li C, Zhang X, Hu Q, Xu W, Sun J, Yang R, Li X, Zhou R, Lian S, Gu J, Wu J, Zhao Y, Wu R. Yao W, et al. Clin Appl Thromb Hemost. 2017 Oct;23(7):851-858. doi: 10.1177/1076029616679507. Epub 2016 Dec 5. Clin Appl Thromb Hemost. 2017. PMID: 27920236 Free article.

3

Low-dose immune tolerance induction alone or with immunosuppressants according to prognostic risk factors in Chinese children with hemophilia A inhibitors.

Li Z, Chen Z, Liu G, Cheng X, Yao W, Huang K, Li G, Zhen Y, Wu X, Cai S, Poon MC, Wu R. Li Z, et al. Among authors: yao w. Res Pract Thromb Haemost. 2021 Jul 14;5(5):e12562. doi: 10.1002/rth2.12562. eCollection 2021 Jul. Res Pract Thromb Haemost. 2021. PMID: 34278191 Free PMC article.

4

Significant reduction in hemarthrosis in boys with severe hemophilia A: The China hemophilia individualized low-dose secondary prophylaxis study.

Wu R, Li X, Yao W, Zhang Q, Zhou M, Zhang N, Yang S, Chen Z, Wang Y, Kuang Y, Tang L, Zhen Y, Abad A, Doria AS, Hilliard P, Ignas DM, Mathew P, Stephens D, Blanchette VS, Luke KH. Wu R, et al. Among authors: yao w. Res Pract Thromb Haemost. 2021 Sep 18;5(6):e12552. doi: 10.1002/rth2.12552. eCollection 2021 Aug. Res Pract Thromb Haemost. 2021. PMID: 34568725 Free PMC article.

5

Nephrotic syndrome in two haemophilia B children with inhibitor under low-dose immune tolerance induction combined with rituximab-based immunosuppressant protocol.

Li Z, Liu G, Yao W, Chen Z, Li G, Cheng X, Zhen Y, Ai D, Huang K, Poon MC, Wu R. Li Z, et al. Among authors: yao w. Haemophilia. 2022 Mar;28(2):e42-e45. doi: 10.1111/hae.14471. Epub 2021 Dec 22. Haemophilia. 2022. PMID: 34936170 No abstract available.

6

Eradication of FIX inhibitor in haemophilia B children using low-dose immune tolerance induction with rituximab-based immunosuppressive agent(s) in China.

Li Z, Liu G, Yao W, Chen Z, Li G, Cheng X, Zhen Y, Ai D, Huang K, Sun J, Poon MC, Wu R. Li Z, et al. Among authors: yao w. Haemophilia. 2022 Jul;28(4):625-632. doi: 10.1111/hae.14577. Epub 2022 May 3. Haemophilia. 2022. PMID: 35503087

7

Low-dose immune tolerance induction in children with severe hemophilia A with high-titer inhibitors: Type of factor 8 mutation and outcomes.

Sun J, Li Z, Li G, Huang K, Ai D, Liu G, Yao W, Xie X, Gu H, Zhen Y, Chen Z, Wu R. Sun J, et al. Among authors: yao w. Res Pract Thromb Haemost. 2022 Oct 26;6(7):e12824. doi: 10.1002/rth2.12824. eCollection 2022 Oct. Res Pract Thromb Haemost. 2022. PMID: 36313984 Free PMC article.

8

The efficacy of the rituximab-containing rescue-regimen for severe hemophilia A inhibitor children who relapsed following successful immune tolerance induction with rituximab in China.

Li Z, Li Z, Sun J, Cheng X, Liu G, Yao W, Huang K, Ai D, Chen Z, Li G, Zhen Y, Poon MC, Wu R. Li Z, et al. Among authors: yao w. Thromb Res. 2023 Mar;223:123-126. doi: 10.1016/j.thromres.2023.01.025. Epub 2023 Feb 2. Thromb Res. 2023. PMID: 36739806 No abstract available.

9

The efficacy of sequential MMF-rescue-regimen to eradicate inhibitors for refractory severe hemophilia A inhibitor children in China.

Li Z, Li Z, Sun J, Cheng X, Liu G, Yao W, Huang K, Ai D, Chen Z, Li G, Zhen Y, Poon MC, Wu R. Li Z, et al. Among authors: yao w. Thromb Res. 2023 Apr;224:60-64. doi: 10.1016/j.thromres.2023.02.011. Epub 2023 Feb 24. Thromb Res. 2023. PMID: 36863259 No abstract available.

10

Low-dose immune tolerance induction therapy in severe hemophilia a children in China: Starting earlier resulted in better inhibitor eradication outcomes.

Li Z, Sun J, Li Z, Chen Z, Liu G, Yao W, Li G, Zhen Y, Cheng X, Ai D, Huang K, Poon MC, Wu R. Li Z, et al. Among authors: yao w. Thromb Res. 2023 May;225:33-38. doi: 10.1016/j.thromres.2023.02.016. Epub 2023 Mar 5. Thromb Res. 2023. PMID: 36934482 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,080 results

Search Page